For comments, suggestions
Created with Raphaël 2.1.0 25.06.1996 Opening of the national phase 30.06.1998 Publication of the PCT application (A) 30.11.2000 Publication of the decision of grant (F2) 31.05.2001 Completion of the opposition filing period 31.05.2001 Issuance of patent (G2) 27.06.2001 Substantive examination 15.09.2013 Publication of expiration of the patent

Patent expired


(11)Number of the document1558
(21)Number of the application96-0244
(22)Filing date of the application1993.09.15
 Date of filing the request for examination (pe raspunderea solicitantului) 04.12.1998
(71)Name(s) of applicant(s), code of the countryGENENTECH, INC., US;
(72)Name(s) of inventor(s), code of the countryCLARK, Ross, G., US;
(73)Name(s) of owner(s), code of the countryGENENTECH, INC., US;
(54)Title of the inventionMethod of prophylaxis of mammal acute renal insufficieny utilizing IGF-I insulinlike growth factor
(13)Kind-of-document code
G2, BOPI 06/2001
F2, BOPI 11/2000
A, BOPI 06/1998
(51)International Patent Classification A61K 38/27 (2006.01); A61K 38/30 (2006.01);
(19)CountryUS
(41)Date of publication of the application1998.06.30
(45)Date of publication of patent granting decision:2000.11.30
(47)Date of issuance of patent2001.06.30
(30)Priority07/949,594, 1992.09.22, US
(74)Patent attorneySIMANENKOVA Tatiana, Str. Andrei Doga 2/1, MD-2024, Chişinău, Republica Moldova
(85)Date of introducing the national procedure1996.06.25
(86)International applicationPCT/US1993/008734, 1993.09.15
(87)International publicationWO 1994/06461, 1994.03.31
 Expired patents; Date of expiration2014.01.31
 Payment for maintenance up to the date2013.09.15
Up
/inventions/Details.aspx?id=96-0244